Lightning Round OT: Tekelec, Jazz Pharma and More
Jazz Pharmaceuticals : Cramer likes JAZZ as a speculation biotech play.
Immunogen : Cramer is bullish on IMGN after the company’s strong showing at the recent American Society of Hematology conference.
Tekelec : TKLC is a buy, Cramer said, especially on its recent pullback. He likes it as a play on the growth in the mobile Internet space.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org